Literature DB >> 22970935

Mechanistic differences in permeation behavior of supersaturated and solubilized solutions of carbamazepine revealed by nuclear magnetic resonance measurements.

Keisuke Ueda1, Kenjirou Higashi, Waree Limwikrant, Shuichi Sekine, Toshiharu Horie, Keiji Yamamoto, Kunikazu Moribe.   

Abstract

A solid dispersion (SPD) of carbamazepine (CBZ) with hydroxypropyl methylcellulose acetate succinate (HPMC-AS) was prepared by the spray drying method. The apparent solubility (37 °C, pH 7.4) of CBZ observed with the SPD was over 3 times higher than the solubility of unprocessed CBZ. The supersaturated solution was stable for 7 days. A higher concentration of CBZ in aqueous medium was also achieved by mixing with Poloxamer 407 (P407), a solubilizing agent. From permeation studies of CBZ using Caco-2 monolayers and dialysis membranes, we observed improved CBZ permeation across the membrane in the supersaturated solution of CBZ/HPMC-AS SPD. On the contrary, the CBZ-solubilized P407 solution exhibited poor permeation by CBZ. The chemical shifts of CBZ on the (1)H NMR spectrum from CBZ/HPMC-AS SPD solution were not altered significantly by coexistence with HPMC-AS. In contrast, an upfield shift of CBZ was observed in the CBZ/P407 solution. The spin-lattice relaxation time (T(1)) over spin-spin relaxation time (T(2)) indicated that the mobility of CBZ in the HPMC-AS solution was much lower than that in water. Meanwhile, the mobility of CBZ in P407 solution was significantly higher than that in water. NMR data indicate that CBZ does not strongly interact with HPMC-AS. CBZ mobility was suppressed due to self-association and microviscosity around CBZ, which do not affect permeation behavior. Most of the CBZ molecules in the CBZ/P407 solution were solubilized in the hydrophobic core of P407, and a few were free to permeate the membrane. The molecular state of CBZ, as evaluated by NMR measurements, directly correlated with permeation behavior.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22970935     DOI: 10.1021/mp300083e

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  7 in total

Review 1.  Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.

Authors:  Justin S LaFountaine; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-08-26       Impact factor: 3.246

2.  Phase Behavior of Resveratrol Solid Dispersions Upon Addition to Aqueous media.

Authors:  Lindsay A Wegiel; Laura I Mosquera-Giraldo; Lisa J Mauer; Kevin J Edgar; Lynne S Taylor
Journal:  Pharm Res       Date:  2015-05-15       Impact factor: 4.200

3.  Dual-mechanism gastroretentive drug delivery system loaded with an amorphous solid dispersion prepared by hot-melt extrusion.

Authors:  Anh Q Vo; Xin Feng; Manjeet Pimparade; Xinyou Ye; Dong Wuk Kim; Scott T Martin; Michael A Repka
Journal:  Eur J Pharm Sci       Date:  2017-02-28       Impact factor: 4.384

4.  Insights into atomic-level interaction between mefenamic acid and eudragit EPO in a supersaturated solution by high-resolution magic-angle spinning NMR spectroscopy.

Authors:  Kenjirou Higashi; Kazutoshi Yamamoto; Manoj Kumar Pandey; Kamal H Mroue; Kunikazu Moribe; Keiji Yamamoto; Ayyalusamy Ramamoorthy
Journal:  Mol Pharm       Date:  2013-12-09       Impact factor: 4.939

5.  Dual mechanism of microenvironmental pH modulation and foam melt extrusion to enhance performance of HPMCAS based amorphous solid dispersion.

Authors:  Anh Q Vo; Xin Feng; Jiaxiang Zhang; Feng Zhang; Michael A Repka
Journal:  Int J Pharm       Date:  2018-08-21       Impact factor: 5.875

6.  Investigating how the attributes of self-associated drug complexes influence the passive transport of molecules through biological membranes.

Authors:  R Inacio; D Barlow; X Kong; J Keeble; S A Jones
Journal:  Eur J Pharm Biopharm       Date:  2016-03-08       Impact factor: 5.571

Review 7.  Mechanisms of increased bioavailability through amorphous solid dispersions: a review.

Authors:  Andreas Schittny; Jörg Huwyler; Maxim Puchkov
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.